Neural Regeneration Research,
Journal Year:
2023,
Volume and Issue:
19(5), P. 1006 - 1012
Published: Sept. 22, 2023
Amyotrophic
lateral
sclerosis
is
a
very
disabling
disease
due
to
the
degeneration
of
motor
neurons.
Symptoms
include
muscle
weakness
and
atrophy,
spasticity,
progressive
paralysis.
Currently,
there
no
treatment
reverse
damage
neurons
cure
amyotrophic
sclerosis.
The
only
two
treatments
actually
approved,
riluzole
edaravone,
have
shown
mitigated
beneficial
effects.
difficulty
find
lies
in
complexity
multifaceted
pattern
pathogenesis.
Among
mechanisms,
abnormal
RNA
metabolism,
nucleocytoplasmic
transport
defects,
accumulation
unfolded
protein,
mitochondrial
dysfunction
would
fine
induce
oxidative
vice
versa.
A
potent
therapeutic
strategy
will
be
molecules
that
break
this
vicious
circle.
Sharpening
nuclear
factor
erythroid-2
related
2
signaling
may
fulfill
objective
since
has
multitarget
profile
controlling
antioxidant
defense,
functioning,
inflammation.
We
here
discuss
interest
developing
2-based
therapy
regard
pathophysiological
mechanisms
we
provide
general
overview
attempted
clinical
assays
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(2), P. 408 - 408
Published: Feb. 17, 2022
Free
radicals
are
formed
as
a
part
of
normal
metabolic
activities
but
neutralized
by
the
endogenous
antioxidants
present
in
cells/tissue,
thus
maintaining
redox
balance.
This
balance
is
disrupted
certain
neuropathophysiological
conditions,
causing
oxidative
stress,
which
implicated
several
progressive
neurodegenerative
diseases.
Following
neuronal
injury,
secondary
injury
progression
also
caused
excessive
production
free
radicals.
Highly
reactive
radicals,
mainly
oxygen
species
(ROS)
and
nitrogen
(RNS),
damage
cell
membrane,
proteins,
DNA,
triggers
self-propagating
inflammatory
cascade
degenerative
events.
Dysfunctional
mitochondria
under
stress
conditions
considered
key
mediator
neurodegeneration.
Exogenous
delivery
holds
promise
to
alleviate
regain
In
this
regard,
natural
synthetic
have
been
evaluated.
Despite
promising
results
preclinical
studies,
clinical
translation
therapy
treat
diseases
remains
elusive.
The
issues
could
be
their
low
bioavailability,
instability,
limited
transport
target
tissue,
and/or
poor
antioxidant
capacity,
requiring
repeated
high
dosing,
cannot
administered
humans
because
dose-limiting
toxicity.
Our
laboratory
investigating
nanoparticle-mediated
enzymes
address
some
above
issues.
Apart
from
being
endogenous,
main
advantage
catalytic
mechanism
action;
hence,
they
significantly
more
effective
at
lower
doses
detoxifying
deleterious
effects
than
nonenzymatic
antioxidants.
review
provides
comprehensive
analysis
potential
therapy,
challenges
translation,
role
nanoparticles/drug
systems
play
addressing
these
challenges.
Cells,
Journal Year:
2022,
Volume and Issue:
11(13), P. 2049 - 2049
Published: June 28, 2022
Amyotrophic
lateral
sclerosis
(ALS)
is
a
rapidly
progressive
and
highly
fatal
neurodegenerative
disease.
Although
the
pathogenesis
of
ALS
remains
unclear,
increasing
evidence
suggests
that
key
contributing
factor
mitochondrial
dysfunction.
Mitochondria
are
organelles
in
eukaryotic
cells
responsible
for
bioenergy
production,
cellular
metabolism,
signal
transduction,
calcium
homeostasis,
immune
responses
stability
their
function
plays
crucial
role
neurons.
A
single
disorder
or
defect
can
lead
to
pathological
changes
cells,
such
as
an
impaired
buffer
period,
excessive
generation
free
radicals,
increased
membrane
permeability,
oxidative
stress
(OS).
Recent
research
has
also
shown
these
dysfunctions
associated
with
believed
be
commonly
involved
This
article
reviews
latest
on
dysfunction
its
impact
progression
ALS,
specific
attention
potential
novel
therapeutic
strategies
targeting
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(4), P. 834 - 834
Published: March 29, 2023
Reduced
glutathione
(GSH)
is
the
most
abundant
non-protein
endogenous
thiol.
It
a
ubiquitous
molecule
produced
in
organs,
but
its
synthesis
predominantly
liver,
tissue
charge
of
storing
and
distributing
it.
GSH
involved
detoxification
free
radicals,
peroxides
xenobiotics
(drugs,
pollutants,
carcinogens,
etc.),
protects
biological
membranes
from
lipid
peroxidation,
an
important
regulator
cell
homeostasis,
since
it
participates
signaling
redox,
regulation
degradation
proteins
(S-glutathionylation),
signal
transduction,
various
apoptotic
processes,
gene
expression,
proliferation,
DNA
RNA
synthesis,
etc.
transport
vital
step
cellular
homeostasis
supported
by
liver
through
providing
extrahepatic
organs
(such
as
kidney,
lung,
intestine,
brain,
among
others)
with
said
antioxidant.
The
wide
range
functions
within
which
shows
that
glutathione’s
role
goes
beyond
being
simple
antioxidant
agent;
therefore,
importance
this
tripeptide
needs
to
be
reassessed
broader
metabolic
perspective.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 762 - 762
Published: June 24, 2024
Neurodegenerative
diseases
are
a
significant
challenge
to
global
healthcare,
and
oxidative
stress
plays
crucial
role
in
their
development.
This
paper
presents
comprehensive
analysis
of
the
neuroprotective
potential
olive
oil,
with
primary
focus
on
its
antioxidant
properties.
The
chemical
composition
including
key
antioxidants,
such
as
oleuropein,
hydroxytyrosol,
oleocanthal,
is
systematically
examined.
mechanisms
by
which
these
compounds
provide
neuroprotection,
counteracting
damage
modulating
pathways,
explored.
efficacy
oil
evaluated
synthesizing
findings
from
various
sources,
vitro
studies,
animal
models,
clinical
trials.
integration
into
dietary
patterns,
particularly
Mediterranean
diet,
broader
implications
neurodegenerative
disease
prevention
also
discussed.
challenges
translating
preclinical
applications
acknowledged
future
research
directions
proposed
better
understand
mitigating
risk
conditions.
review
highlights
not
only
component,
but
promising
candidate
preventive
neurology,
advocating
for
further
investigation
context
diseases.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(8), P. 1511 - 1511
Published: Aug. 2, 2022
Neurodegenerative
diseases
are
characterized
by
gradually
progressive,
selective
loss
of
anatomically
or
physiologically
related
neuronal
systems
that
produce
brain
damage
from
which
there
is
no
recovery.
Despite
the
differences
in
clinical
manifestations
and
vulnerability,
pathological
processes
appear
to
be
similar,
suggesting
common
neurodegenerative
pathways.
It
well
known
oxidative
stress
production
reactive
oxygen
radicals
plays
a
key
role
cell
damage.
has
been
proposed
this
stress,
among
other
mechanisms,
could
contribute
degeneration
might
one
factors
triggering
development
these
pathologies.
Another
feature
most
neuron
hyperexcitability,
an
aberrant
electrical
activity.
This
review,
focusing
mainly
on
primary
motor
cortex
pyramidal
neurons,
critically
evaluates
idea
inflammation
may
involved
neurodegeneration
via
their
capacity
increase
membrane
excitability.
Annals of Clinical and Translational Neurology,
Journal Year:
2023,
Volume and Issue:
10(11), P. 1948 - 1971
Published: Aug. 28, 2023
Abstract
Numerous
potential
amyotrophic
lateral
sclerosis
(ALS)‐relevant
pathways
have
been
hypothesized
and
studied
preclinically,
with
subsequent
translation
to
clinical
trial.
However,
few
successes
observed
only
modest
effects.
Along
an
improved
but
incomplete
understanding
of
ALS
as
a
neurodegenerative
disease
is
the
evolution
more
sophisticated
diverse
in
vitro
vivo
preclinical
modeling
platforms,
well
trial
designs.
We
highlight
proposed
pathological
that
major
therapeutic
targets
for
investigational
compounds.
It
likely
failures
so
many
these
compounds
may
not
occurred
because
lack
efficacy
rather
would
help
define
appropriate
pathway,
failure
establish
target
engagement.
These
challenges
are
compounded
by
shortcomings
design,
including
biomarkers
could
predict
success
studies
underpowered.
Although
research
investments
provided
abundant
insights
into
new
ALS‐relevant
pathways,
most
yet
developed
fully
result
study.
In
this
review,
we
detail
some
important,
well‐established
therapeutics
targeting
them,
design.
With
translational
efforts
over
last
three
decades
investigation,
propose
scientists
clinicians
choose
revisit
reviewed
here
eye
toward
improving
modeling,
biomarker
development,
investment
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12613 - 12613
Published: Nov. 24, 2024
Neurodegenerative
diseases,
such
as
Alzheimer's,
Parkinson's,
ALS,
and
Huntington's,
remain
formidable
challenges
in
medicine,
with
their
relentless
progression
limited
therapeutic
options.
These
diseases
arise
from
a
web
of
molecular
disturbances-misfolded
proteins,
chronic
neuroinflammation,
mitochondrial
dysfunction,
genetic
mutations-that
slowly
dismantle
neuronal
integrity.
Yet,
recent
scientific
breakthroughs
are
opening
new
paths
to
intervene
these
once-intractable
conditions.
This
review
synthesizes
the
latest
insights
into
underlying
dynamics
neurodegeneration,
revealing
how
intertwined
pathways
drive
course
diseases.
With
an
eye
on
most
promising
advances,
we
explore
innovative
therapies
emerging
cutting-edge
research:
nanotechnology-based
drug
delivery
systems
capable
navigating
blood-brain
barrier,
gene-editing
tools
like
CRISPR
designed
correct
harmful
variants,
stem
cell
strategies
that
not
only
replace
lost
neurons
but
foster
neuroprotective
environments.
Pharmacogenomics
is
reshaping
treatment
personalization,
enabling
tailored
align
individual
profiles,
while
diagnostics
biomarkers
ushering
era
early,
precise
disease
detection.
Furthermore,
novel
perspectives
gut-brain
axis
sparking
interest
mounting
evidence
suggests
microbiome
modulation
may
play
role
reducing
neuroinflammatory
responses
linked
neurodegenerative
progression.
Taken
together,
advances
signal
shift
toward
comprehensive,
personalized
approach
could
transform
care.
By
integrating
techniques,
this
offers
forward-looking
perspective
future
where
treatments
aim
just
manage
symptoms
fundamentally
alter
progression,
presenting
renewed
hope
for
improved
patient
outcomes.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(5), P. 2580 - 2580
Published: Feb. 25, 2022
Amyotrophic
lateral
sclerosis
(ALS)
is
a
devastating
neurodegenerative
disease,
characterized
by
the
progressive
loss
of
lower
motor
neurons,
weakness
and
muscle
atrophy.
ALS
lacks
an
effective
cure
diagnosis
often
made
exclusion.
Thus,
it
imperative
to
search
for
biomarkers.
Biomarkers
can
help
in
understanding
pathomechanisms,
identification
targets
treatment
development
therapies.
Peripheral
blood
mononuclear
cells
(PBMCs)
represent
valid
source
biomarkers
compared
cerebrospinal
fluid,
as
they
are
simple
collect,
plasma,
because
possibility
detecting
expressed
proteins.
They
reliable
model
patients’
stratification.
This
review
provides
overview
on
PBMCs
potential
ALS.
We
focused
altered
RNA
metabolism
(coding/non-coding
RNA),
including
processing,
mRNA
stabilization,
transport
translation
regulation.
addressed
protein
abnormalities
(aggregation,
misfolding
modifications);
specifically,
we
highlighted
that
SOD1
appears
be
most
characterizing
Finally,
emphasized
correlation
between
biological
parameters
disease
phenotypes,
regards
prognosis,
severity
clinical
features.
In
conclusion,
even
though
further
studies
needed
standardize
use
tool
biomarker
investigation,
promising
approach
research.
Sclerosis,
Journal Year:
2025,
Volume and Issue:
3(1), P. 1 - 1
Published: Jan. 12, 2025
Background:
Amyotrophic
lateral
sclerosis
(ALS)
and
multiple
(MS)
are,
in
essence,
neurodegenerative
disorders
with
significant
individual,
social,
economic
burdens
worldwide.
Despite
having
different
clinical
onset
evolution,
the
two
diseases
share
common
risk
factors
underlying
pathophysiological
mechanisms.
Environmental
are
particularly
interesting,
considering
available
effective
counter
strategies.
High-fat
diets
remain
a
element
that
negatively
impacts
evolution
of
several
disorders,
including
ALS
MS.
Focusing
on
changeable
disease-related
aspects
is
increasingly
appealing
context
lack
an
treatment.
Methods:
This
review
aims
to
offer
updated
overview
influence
high-fat
modulating
progression
MS,
based
search
three
relevant
online
databases.
Results:
In
first
part,
shared
mechanisms
MS
shown,
differences
between
highlighted.
Subsequently,
most
research
this
topic
conducted
animal
models
humans
presented,
bringing
additional
proof
critical
role
neurodegeneration.
Finally,
current
knowledge,
authors
potential
therapeutic
approaches
future
directions
better
control
nutrition
patients,
hoping
increase
survival
quality
life.
Conclusions:
impact